Showing results (401-410 of 434) with videos related to
Sort By:
Pageof 44
Haematologica|February 2, 2017
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14Mark Hertzberg, Maher K Gandhi, Judith Trotman, et al.Lancet (London, England)|March 27, 2020
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre studyMichael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2019
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, et al.Journal for Immunotherapy of Cancer|January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primaryAtara Posner, Tharani Sivakumaran, Andrew Pattison, et al.Journal of Neuroendocrinology|May 16, 2024
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task forceAnna Koumarianou, Pier Luigi Filosso, Lisa Bodei, et al.Cancer Discovery|January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysisTiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical ImplementationRonald Boellaard, Irène Buvat, Christophe Nioche, et al.Theranostics|October 14, 2020
First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancersAndrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.Journal of Medical Genetics|September 12, 2018
Bayesian approach to determining penetrance of pathogenic SDH variantsDiana E Benn, Ying Zhu, Katrina A Andrews, et al.Journal of Neuroendocrinology|December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task ForceVikas Prasad, Anna Koumarianou, Timm Denecke, et al.Pageof 44